Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ensor

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Endocrinology, Diabetes & Obesity|April 8, 2016
Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 DiabetesMark Ensor, Amy B Banfield, Rebecca R Smith, et al.
Analytical Chemistry|August 23, 2012
Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenylsKrystal Teasley Hamorsky, C Mark Ensor, Emre Dikici, et al.
Hepato-Gastroenterology|October 24, 2003
Regression of hepatocellular cancer in a patient treated with arginine deiminaseSteven A Curley, John S Bomalaski, C Mark Ensor, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2021
Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir AlSiraj, Sean E Thatcher, Ching Ling Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2002
Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological propertiesFrederick W Holtsberg, Charles Mark Ensor, Marion R Steiner, et al.
The Biochemical Journal|April 20, 2002
Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxinJ Brandon Thomas, Frederick W Holtsberg, C Mark Ensor, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 16, 2002
Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide productionBrian J Dillon, Frederick W Holtsberg, C Mark Ensor, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 13, 2019
Pseudomonas aeruginosa-derived pyocyanin reduces adipocyte differentiation, body weight, and fat mass as mechanisms contributing to septic cachexiaNika Larian, Mark Ensor, Sean E Thatcher, et al.
Clinical Science (London, England : 1979)|April 9, 2025
Nicotine promotes AngII-induced abdominal aortic aortopathies in female and male mice: role of sex hormonesMark Ensor, Sean E Thatcher, Kristen McQuerry, et al.
Cancer|February 11, 2004
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivationBrian J Dillon, Victor G Prieto, Steven A Curley, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Endocrinology, Diabetes & Obesity|April 8, 2016
Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 DiabetesMark Ensor, Amy B Banfield, Rebecca R Smith, et al.
Analytical Chemistry|August 23, 2012
Bioluminescence inhibition assay for the detection of hydroxylated polychlorinated biphenylsKrystal Teasley Hamorsky, C Mark Ensor, Emre Dikici, et al.
Hepato-Gastroenterology|October 24, 2003
Regression of hepatocellular cancer in a patient treated with arginine deiminaseSteven A Curley, John S Bomalaski, C Mark Ensor, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2021
Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir AlSiraj, Sean E Thatcher, Ching Ling Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2002
Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological propertiesFrederick W Holtsberg, Charles Mark Ensor, Marion R Steiner, et al.
The Biochemical Journal|April 20, 2002
Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxinJ Brandon Thomas, Frederick W Holtsberg, C Mark Ensor, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 16, 2002
Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide productionBrian J Dillon, Frederick W Holtsberg, C Mark Ensor, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 13, 2019
Pseudomonas aeruginosa-derived pyocyanin reduces adipocyte differentiation, body weight, and fat mass as mechanisms contributing to septic cachexiaNika Larian, Mark Ensor, Sean E Thatcher, et al.
Clinical Science (London, England : 1979)|April 9, 2025
Nicotine promotes AngII-induced abdominal aortic aortopathies in female and male mice: role of sex hormonesMark Ensor, Sean E Thatcher, Kristen McQuerry, et al.
Cancer|February 11, 2004
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivationBrian J Dillon, Victor G Prieto, Steven A Curley, et al.
Pageof 4